These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1311687)

  • 101. Chronic haloperidol treatment attenuates receptor-mediated phosphoinositide turnover in rat brain slices.
    Li R; Wing LL; Shen Y; Wyatt RJ; Kirch DG; Chuang DM
    Neurosci Lett; 1991 Aug; 129(1):81-5. PubMed ID: 1656342
    [TBL] [Abstract][Full Text] [Related]  

  • 102. 5-HT2 receptor-stimulated inositol phosphate formation in rat aortic myocytes.
    Cory RN; Berta P; Haiech J; Bockaert J
    Eur J Pharmacol; 1986 Nov; 131(1):153-7. PubMed ID: 3028826
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Serotonin activates Cl- channels in the apical membrane of rat choroid plexus epithelial cells.
    Garner C; Feniuk W; Brown PD
    Eur J Pharmacol; 1993 Aug; 239(1-3):31-7. PubMed ID: 8223911
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The effects of serotonin antagonists in a behavioral despair procedure in mice.
    Luttinger D; Freedman M; Hamel L; Ward SJ; Perrone M
    Eur J Pharmacol; 1984 Dec; 107(1):53-8. PubMed ID: 6526071
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Simultaneous effects of the platelet 5-HT2 and alpha 2-adrenergic receptor populations on phosphoinositide hydrolysis.
    Rigatti BW; Paleos GA; Mann JJ
    Life Sci; 1992; 50(3):169-80. PubMed ID: 1309935
    [TBL] [Abstract][Full Text] [Related]  

  • 106. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors.
    Robertson DW; Bloomquist W; Wong DT; Cohen ML
    Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Biochemical characterization of phosphoinositide hydrolysis stimulated by 5-HT3 receptor agonists.
    Edwards E; Ashby CR; Wang RY
    Neuroreport; 1992 Dec; 3(12):1081-4. PubMed ID: 1362896
    [TBL] [Abstract][Full Text] [Related]  

  • 108. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype.
    King BH; Brazell C; Dourish CT; Middlemiss DN
    Neurosci Lett; 1989 Oct; 105(1-2):174-6. PubMed ID: 2562060
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Modulation of neurosteroid synthesis/accumulation by L-ascorbic acid in rat brain tissue: inhibition by selected serotonin antagonists.
    Roscetti G; Del Carmine R; Trabucchi M; Massotti M; Purdy RH; Barbaccia ML
    J Neurochem; 1998 Sep; 71(3):1108-17. PubMed ID: 9721735
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Synthesis, affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors and structure-activity relationships of a series of cyproheptadine analogues.
    Honrubia MA; Rodriguez J; Dominguez R; Lozoya E; Manaut F; Seijas JA; Villaverde MC; Calleja JM; Cadavid MI; Maayani S; Sanz F; Loza MI
    Chem Pharm Bull (Tokyo); 1997 May; 45(5):842-8. PubMed ID: 9178521
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.
    Cohen ML; Fuller RW
    Life Sci; 1983 Feb; 32(7):711-8. PubMed ID: 6827905
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Serotonin, a potent modulator of arachidonic acid turnover, interaction with glutamatergic receptor in brain cortex.
    Strosznajder J; Samochocki M; Duran M
    Neurochem Int; 1994 Aug; 25(2):193-9. PubMed ID: 7994200
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Influence of stress and antidepressant treatment on 5-HT-stimulated phosphoinositide hydrolysis in rat brain.
    Kawanami T; Morinobu S; Totsuka S; Endoh M
    Eur J Pharmacol; 1992 Jun; 216(3):385-92. PubMed ID: 1330582
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Drug effects on the 5-HT response of Schistosoma mansoni.
    Willcockson WS; Hillman GR
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1984; 77(1):199-203. PubMed ID: 6141876
    [TBL] [Abstract][Full Text] [Related]  

  • 115. 5-HT-1a and 5-HT-1b selectivity of two phenylpiperazine derivatives: evidence for 5-HT-1b heterogeneity.
    Asarch KB; Ransom RW; Shih JC
    Life Sci; 1985 Apr; 36(13):1265-73. PubMed ID: 3982214
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Selective 5HT-2 antagonists inhibit serotonin stimulated phosphatidylinositol metabolism in cerebral cortex.
    Conn PJ; Sanders-Bush E
    Neuropharmacology; 1984 Aug; 23(8):993-6. PubMed ID: 6483122
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Regional serotonin receptor studies: chronic methysergide treatment induces a selective and dose-dependent decrease in serotonin-2 receptors in mouse cerebral cortex.
    May PC; Morgan DG; Finch CE
    Life Sci; 1986 May; 38(19):1741-7. PubMed ID: 3702603
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Modulation of serotonin2A/2C receptors and these receptor-linked phosphoinositide system by ethanol.
    Pandey SC; Pandey GN
    Behav Brain Res; 1996; 73(1-2):235-8. PubMed ID: 8788509
    [TBL] [Abstract][Full Text] [Related]  

  • 119. GABAB receptor activation inhibits 5-hydroxytryptamine-stimulated inositol phospholipid turnover in mouse cerebral cortex.
    Godfrey PP; Grahame-Smith DG; Gray JA
    Eur J Pharmacol; 1988 Jul; 152(1-2):185-8. PubMed ID: 2850199
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Evidence that tolerance to the anxiogenic-like effects of mCPP does not involve alteration in the function of 5-HT(2C) receptors in the rat choroid plexus.
    Griebel G; Moreau JL; Jenck F; Mutel V; Martin JR; Misslin R
    Behav Pharmacol; 1994 Oct; 5(6):642-645. PubMed ID: 11224245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.